On Friday, the US Food and Drug Administration is holding its first hearing to assess the safety and efficacy of these CBD products.
„Its critical that we address these unanswered questions about CBD and other cannabis and cannabis-derived products to help inform the FDAs regulatory oversight of these products,“ he said.
